Literature DB >> 20492578

Identifying fibromyalgia-associated symptoms and conditions from a clinical perspective: a step toward evaluating healthcare resource utilization in fibromyalgia.

Stuart L Silverman1, James Harnett, Gergana Zlateva, Jack Mardekian.   

Abstract

OBJECTIVE: The study aims to determine from the physician's perspective, the conditions and symptoms most relevant to the diagnosis of fibromyalgia (FM) for identifying International Classification of Diseases-diagnosis codes and prescription medications to evaluate FM-related healthcare resource utilization.
METHODS: A questionnaire was administered using an online physician network (SERMO™) from which responses of 102 physicians were evaluated: anesthesiologists (n = 6), neurologists (n = 18), primary care physicians (n = 16), pain specialists (n = 16), psychiatrists (n = 15), and rheumatologists (n = 31). Physicians scored the relative importance to a diagnosis of FM (0 = least relevant/important, 10 = most relevant/important) of 24 conditions and symptoms derived from a list provided by the National Data Bank for Rheumatic Diseases. Conditions and symptoms with mean scores ≥ 5 were considered the most relevant. Other survey questions included treatment goals, assessment of disease severity, medication use, and characterization of the physicians' experience and clinical practice.
RESULTS: Ten conditions and symptoms (mean score) were reported as most relevant: Muscle pain (8.7), Fatigue/tiredness (8.5), Insomnia (8.0), Depression (7.8), Thinking/remembering (6.7), Nervousness (6.0), Muscle weakness (5.9), Headache (5.7), Irritable bowel syndrome (5.5), and Pain/cramps in abdomen (5.1). Treatment goals, severity assessment, and use of medications were generally similar across physician specialties.
CONCLUSIONS: This survey identified 10 conditions and symptoms that physician respondents considered most relevant to a diagnosis of FM. Further evaluation to determine how these conditions and symptoms contribute to FM-associated healthcare resource utilization is warranted.
© 2010 Pfizer Inc. Pain Practice © 2010 World Institute of Pain.

Entities:  

Mesh:

Year:  2010        PMID: 20492578     DOI: 10.1111/j.1533-2500.2010.00383.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  9 in total

1.  The effects of long- and short-term interdisciplinary treatment approaches in women with fibromyalgia: a randomized controlled trial.

Authors:  Ilknur Saral; Dilsad Sindel; Sina Esmaeilzadeh; Hanife Ozlem Sertel-Berk; Aydan Oral
Journal:  Rheumatol Int       Date:  2016-04-07       Impact factor: 2.631

Review 2.  Latent myofascial trigger points.

Authors:  Hong-You Ge; Lars Arendt-Nielsen
Journal:  Curr Pain Headache Rep       Date:  2011-10

3.  Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.

Authors:  Nicole M Marlow; Kit N Simpson; Ivana A Vaughn; Ara Jo; James S Zoller; Edward B Short
Journal:  Pain Pract       Date:  2017-05-28       Impact factor: 3.183

4.  The relationship between disease severity and defense mechanisms in fibromyalgia syndrome.

Authors:  Ejder Berk; Sema Baykara
Journal:  Turk J Phys Med Rehabil       Date:  2020-03-03

5.  Why should gastroenterologists know about fibromyalgia? Common pathogenesis and clinical implications.

Authors:  Yong Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

6.  Clinical features of headache patients with fibromyalgia comorbidity.

Authors:  Marina de Tommaso; Antonio Federici; Claudia Serpino; Eleonora Vecchio; Giovanni Franco; Michele Sardaro; Marianna Delussi; Paolo Livrea
Journal:  J Headache Pain       Date:  2011-08-17       Impact factor: 7.277

7.  Gender Differences in Symptoms, Health-Related Quality of Life, Sleep Quality, Mental Health, Cognitive Performance, Pain-Cognition, and Positive Health in Spanish Fibromyalgia Individuals: The Al-Ándalus Project.

Authors:  Víctor Segura-Jiménez; Fernando Estévez-López; Alberto Soriano-Maldonado; Inmaculada C Álvarez-Gallardo; Manuel Delgado-Fernández; Jonatan R Ruiz; Virginia A Aparicio
Journal:  Pain Res Manag       Date:  2016-10-27       Impact factor: 3.037

8.  Fibromyalgia diagnostic model derived from combination of American College of Rheumatology 1990 and 2011 criteria.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Asghar Hajiabbasi; Irandokht Shenavar; Babak Ghalehbaghi; Omid Sanaei
Journal:  Korean J Pain       Date:  2019-04-01

9.  Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials.

Authors:  Helen Koechlin; Anna Kharko; Tamara Probst; Julia Pradela; Stefan Buechi; Cosima Locher
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.